Press releases

Découverte d’un nouveau gène dont les mutations sont associées à la maladie de Parkinson

Press release | 16 Sep 2011 - 14h37 | By INSERM PRESS OFFICE
Neurosciences, cognitives sciences, neurology and psychiatry
TO CITE THIS POST :
Press release – Inserm press room Découverte d’un nouveau gène dont les mutations sont associées à la maladie de Parkinson Link : https://presse.inserm.fr/en/francais-decouverte-dun-nouveau-gene-dont-les-mutations-sont-associees-a-la-maladie-de-parkinson/13697/
Medias
Researcher Contact

Marie-Christine Chartier-Harlin et Alain Destée Unité Inserm 837 "Centre de recherche Jean Pierre Aubert" Evénements moléculaires associés aux stades précoces de la maladie de Parkinson Tel : 03 20 16 92 22

Press Contact

presse@inserm.fr

Sources

Translation initiator EIF4G1 mutations in familial Parkinson’s disease Marie-Christine Chartier-Harlin PhD1,2Φ, Justus C. Dachsel PhD3Φ, Carles Vilariño-Güell PhD4Φ, Sarah J. Lincoln BSc3, Frédéric Leprêtre PhD1,2, Mary M. Hulihan MPH3, Jennifer Kachergus BSc3, Austen J Milnerwood PhD4, Lucia Tapia PhD4, Mee-Sook Song PhD4, Emilie Le Rhun MD5, Eugénie Mutez MD1,2,5, Lydie Larvor PhD1,2, Aurélie Duflot BSc1,2, Christel Vanbesien-Mailliot PhD1,2,6, Alexandre Kreisler MD PhD1,2,5, Owen A. Ross PhD3, Kenya Nishioka MD PhD3, Alexandra I. Soto-Ortolaza BSc3, Stephanie A. Cobb BA3, Heather L. Melrose PhD3,Bahareh Behrouz PhD3, Brett H. Keeling BA3, Justin A. Bacon BSc3, Emna Hentati MD3,Lindsey Williams BSc3, Akiko Yanagiya PhD7, Nahum Sonenberg PhD7, Paul J. Lockhart PhD8,Abba C. Zubair MD PhD9, Ryan J. Uitti MD3, Jan O. Aasly MD PhD10, Anna Krygowska-WajsMD11, Grzegorz Opala MD PhD12, Zbigniew K. Wszolek MD3, Roberta Frigerio MD13,Demetrius M. Maraganore MD13, David Gosal MD14, Tim Lynch FRCPI14,15, Michael Hutchinson FRCPI16, Anna Rita Bentivoglio MD PhD17, Enza Maria Valente MD PhD18,William C. Nichols PhD19, Nathan Pankratz PhD20, Tatiana Foroud PhD20, Rachel A. Gibson PhD21, Faycal Hentati MD22, Dennis W. Dickson MD3, Alain Destée MD1,2,5 ‡ and Matthew J. Farrer PhD3,4‡ * Φ ‡These authors contributed equally 1 Univ Lille Nord de France, F-59000 Lille, France 2 Inserm UMR837, IRCL, Place de Verdun - 59045 Lille Cedex, IFR114 IMPRT F-59000 Lille, France 3 Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL32224, USA 4 Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada 5 CHRU, Department of Neurology and Movement Disorders, F-59000 Lille, France 6 USTL, Department of Neurosciences, Villeneuve d’Ascq, F-59655 France 7 Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Montreal, Quebec H3A 3R1, Canada 8 Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Parkville, Victoria 3052, Australia 9 Department of Laboratory Medicine & Pathology, Mayo Clinic, Jacksonville, FL32224, USA 10 Department of Neurology, St. Olav’s Hospital, Trondheim N-7006, Norway 11 Department of Neurology, Collegium Medicum, Jagiellonian University, Krakow 31-358, Poland 12 Department of Neurology, Aging, Degenerative and Cerebrovascular Disorders, Medical University of Silesia, Katowice 40-055, Poland 13 Department of Neurology, Mayo Clinic, Rochester, MN 55909, USA 14 Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin 7, Ireland 15 Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Dublin 4, Ireland 16 Department of Neurology, St Vincent's University Hospital, Dublin 4, Ireland 17 Institute of Neurology, Catholic University, Rome 00168, Italy 18 Mendel Laboratory, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Italy and Dept. of Medical and Surgical Pediatric Sciences, University of Messina, Messina, 98124 Italy 19 Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA 20 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA 21 GlaxoSmithKline Pharmaceuticals, Research and Development, Harlow, Greenford, Hammersmith CM19 5AW, UK 22 Service de Neurologie, Institut National de Neurologie, 1007 La Rabta, Tunis, Tunisia. The American Journal of Human Genetics 2011 Sep 9; 89(3):398-406

fermer
fermer
RSS Youtube